Magri Andrea, Manfredi Giulia Francesca, Smirne Carlo, Pigni Silvia, Burlone Michela Emma, Bellan Mattia, Vercellino Nicole, Minisini Rosalba, Pirisi Mario
Department of Translational Medicine, Università del Piemonte Orientale, 28100 Novara, Italy.
Nuffield Department of Medicine, University of Oxford, Oxford OX3 7JT, UK.
Viruses. 2024 Dec 27;17(1):21. doi: 10.3390/v17010021.
The determinants of hepatitis C virus (HCV) viral load remain incompletely understood and may differ in females, who are relatively protected from the consequences of HCV infection during their reproductive years. We aimed to evaluate how age affects the relationship between sex and viral load. = 922 patients (males = 497, median age 62 years), all naïve to direct antiviral agents, were studied. Females were older (median age 68 vs. 57, < 0.001) and had a higher prevalence of genotype 2 (33% vs. 20%, < 0.001) than males; there was no difference between sexes regarding the METAVIR stage. The median HCV RNA concentration was 1.017 × 10 IU/mL (interquartile range, 0.286-2.400). Among males, the METAVIR stage was the strongest independent predictor of a high viral load (defined as the highest two quartiles), with advanced stages inversely associated with viral load ( = 0.008). In females, age was the only independent predictor, with women aged ≥55 years exhibiting higher loads ( = 0.009). These findings are consistent with data showing that estrogens exert an antiviral effect in in vitro models of HCV. Their declining levels after the menopause may explain the "catch-up" phase of HCV-related liver disease, observed in older women.
丙型肝炎病毒(HCV)病毒载量的决定因素仍未完全明确,在女性中可能有所不同,女性在生育年龄相对受HCV感染后果的影响较小。我们旨在评估年龄如何影响性别与病毒载量之间的关系。对922例患者(男性497例,中位年龄62岁)进行了研究,所有患者均未接受过直接抗病毒药物治疗。女性年龄较大(中位年龄68岁对57岁,P<0.001),2型基因型的患病率高于男性(33%对20%,P<0.001);在METAVIR分期方面,两性之间没有差异。HCV RNA浓度中位数为1.017×10 IU/mL(四分位间距,0.286 - 2.400)。在男性中,METAVIR分期是高病毒载量(定义为最高的两个四分位数)的最强独立预测因素,晚期与病毒载量呈负相关(P = 0.008)。在女性中,年龄是唯一的独立预测因素,≥55岁的女性病毒载量较高(P = 0.009)。这些发现与数据表明雌激素在HCV体外模型中发挥抗病毒作用一致。绝经后雌激素水平下降可能解释了在老年女性中观察到的HCV相关肝病的“追赶”阶段。